LianBio (NASDAQ:LIAN - Get Rating) - Analysts at Jefferies Financial Group lowered their Q1 2022 earnings per share (EPS) estimates for LianBio in a note issued to investors on Wednesday, March 30th. Jefferies Financial Group analyst M. Yee now expects that the company will earn ($0.22) per share for the quarter, down from their previous estimate of ($0.20). Jefferies Financial Group also issued estimates for LianBio's Q2 2022 earnings at ($0.25) EPS, Q3 2022 earnings at ($0.28) EPS, Q4 2022 earnings at ($0.32) EPS, FY2022 earnings at ($1.07) EPS, Q1 2023 earnings at ($0.34) EPS, Q2 2023 earnings at ($0.37) EPS, Q3 2023 earnings at ($0.36) EPS, Q4 2023 earnings at ($0.37) EPS and FY2023 earnings at ($1.44) EPS.
https://www.marketbeat.com/instant-alerts/nasdaq-lian-analyst-earnings-estimates-2022-04/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.